Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 7, 2005, Pages 779-782

  Silva, Melissa T G ^a   Simas, Sonia M ^b   Batista, Terezinha Gfm ^b   Cardarelli, Paola ^c   Tomassini, Therezinha C B ^a  

^a Far Manguinhos   (Brazil)

^b Laboratório de Controle Microbiológico de Antibióticos   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antimicrobial methods; Physalins; Physalis angulata L.

Indexed keywords

CANDIDA ALBICANS; ESCHERICHIA COLI; MAGNOLIOPHYTA; NEISSERIA GONORRHOEAE; PHYSALIS; PHYSALIS ANGULATA; PSEUDOMONAS AERUGINOSA; SOLANACEAE; STAPHYLOCOCCUS AUREUS;

EID: 31544480369     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762005000700018     Document Type: Article

References (22)

1. Bauer AW, Kirby MM, Sherris JC, Turck M 1966. Antibiotic susceptibility testing by a standardized single disk method. Am J Clinl Pathol 45: 493-496.
2. Cáceres A, Menéndez H, Méndez E, Cohobón E, Samayoa BE, Jauregui E, Peralta E, Carrillo G 1995. Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases. J Ethnopharmacol 48: 85-88.
3. Chiang HC, Jaw SM, Chen CF, Kan WS 1993. Antitumor agent, physalin F from Physalis angulata L. Anticancer Res 12: 837-844.
4. CLSI-Clinical and Laboratory Standards Institute 1993. Methods for dilution antimicrobial susceptibility tests for bacterial that grow aerobically, 3rd ed., Approved Standard (M7-A3), Wayne, PA.
5. CLSI-Clinical and Laboratory Standards Institute 2001. Performance standards for antimicrobial susceptibility testing 11th ed., Information supplement (M2-A7 e M7-A5), Wayne, PA.
6. Dos Santos JAA, Ribeiro IM, Drummond D, Silva MTG, Morais ZB, Tomassini TCB 2003. Mollusccidal activity of Physalis angulata l. extracts and fractions on Biomphalaria tenagophila (d' Orbigny, 1835) under laboratory conditions. Mem Inst Oswaldo Cruz 98: 425-428.
7. a ed., São Paulo, v.5.2.1.7.
8. FDA-Food and Drug Administration 1991. Code of Federal Regulation: Food and Drugs - CFR: 21 parts, 300-499, Washington DC: Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register, p. 328-345.
9. Freiburhaus F, Kaminstry R, Nkunya NHH, Brun R 1996. Evaluation of African medicinal plants for their "in vitro" trypanocidal activity. J Ethnopharmacol 55: 1-11.
10. Januário AH, Rodrigues Filho E, Pietro RCLR, Kashima DN, Sato DN, França SC 2002. Antimycobacterial physalins from Physalis angulata L. (Solanaceae). Phytother Res 16: 445-448.
11. Kline RM, Golab T 1965. A simple technique in developing thin-layer bioautography. J Chromatogr 18: 409-411.
12. Nostro A 2000. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett Appl Microbiol 30: 379-384.
13. Ogunlana EO, Ramstad E 1975. Investigations into the antibacterial activities of local plants of Nigeria. Planta Med 27: 354-360.
14. Pietro RCLR, Kashima S, Sato DN, Januário AH, França SC 2000. In vitro antimycobacterial activities of Physalis angulata L. Phytomedicine 7: 335-338.
15. Rahalison L, Hamburguer M, Monod M, Hostettmann K 1994. Antifungal tests phytochemical investigations: comparison of bioautographic methods using phytopathogenic and human pathogenic fungi. Planta Med 60: 41-44.
16. Ray AB, Gupta M 1994. Withasteroids, a growing group of naturally occurring steroidal lactones. In W Herz, GW Kirby, RE Moore, W Steglich, CH Tamm (eds), Progress in the Chemistry of Organic Natural Products, SpringerVerlag, Austria, p. 2-13 and 56-58.
17. Sanches EG, Silva MTG, Ribeiro IM, Tomassini TCB 1997. Evaluation of the antibacterial activity of Physalis angulata L. extracts. Boll Chim Farm 2: 136.
18. Silva MTG, Marques GH, Ribeiro IM, Sanches EG, Tomassini TCB 1999. Evaluation of the bacteria inhibitory profile between native Belém do Pará and Rio de Janeiro cultivated P. angulata L. species against S. aureus, E. coli, K. pneumoniae. Boll Chim Farm 2: 138.
19. Soares MBP, Bellintani MC, Ribeiro I M, Tomassini TCB, Dos Santos RR 2003. Inhibition of macrophage activation and lipopolysaccharide-induced death by seco-steroids purified from Physalis angulata L. Europ J Pharmacol 459: 107-112.
20. Tomassini TCB, Barbi NS, Ribeiro IM, Xavier, DCD, inventors; Fiocruz, Far-Manguinhos assignee 1999. Processo de isolamento de fisalinas a partir de plantas e composições farmacêuticas com atividade anti-protozoa contendo fisalinas. Brazilian patent BR 9904635, July 23, Int. Cl 09/417779.
21. Tomassini TCB, Barbi NS, Ribeiro IM, Xavier DCD 2000. Gênero Physalis - Uma revisão sobre vitaesteróides. Química Nova 23: 47-57.
22. USP-United States Pharmacopoeia 1995. Biological tests and assays. antibiotics-microbial assays, 23rd ed., United States Pharmacopoeia Convention, INC. 1690-1696, Twinbrook Parkway, Rockville, MD.